Related Experiment Video

Updated: Jun 11, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.6K

Left Atrial Hemodynamics and Clinical Utility in Heart Failure

Chang-Yi Lin1, Shu-I Lin1,2, Ying-Hsiang Lee1,2

  • 1Cardiovascular Division, Department of Internal Medicine, Mackay Memorial Hospital, Mackay Medical College, 104217 New Taipei City, Taiwan.

Reviews in Cardiovascular Medicine
|October 2, 2024
PubMed

Insights

Left atrial remodeling is crucial in heart failure (HF). Monitoring and reducing left atrial pressure (LAP) via novel devices offers a new therapeutic strategy for HF patients.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Heart Failure Research

Background:

  • Left ventricular remodeling is well-studied in heart failure (HF).
  • Atrial structural and functional changes in HF, particularly left atrial (LA) remodeling, have received less attention.
  • LA remodeling and its associated pressure (LAP) are increasingly recognized as critical factors in HF pathophysiology.

Purpose of the Study:

  • To review the significance of LA hemodynamic monitoring in heart failure.
  • To discuss the role of left atrial pressure (LAP) as a therapeutic target.
  • To highlight advancements in devices for LAP measurement and decompression.

Main Methods:

  • Literature review focusing on left atrial remodeling and pressure in heart failure.
  • Analysis of studies investigating LA pathophysiology and its clinical implications.
  • Examination of technological advancements in LAP monitoring and management.

Main Results:

  • Left atrial remodeling is a significant, yet understudied, aspect of heart failure.
  • Elevated LAP is a key indicator and potential therapeutic target in HF management.
  • Development of specialized devices enables direct LAP measurement for optimized HF treatment.

Conclusions:

  • Comprehensive understanding of LA pathophysiology is vital for advancing heart failure care.
  • LAP monitoring and decompression represent a promising frontier in HF therapy.
  • Novel technologies facilitate improved management strategies for heart failure patients through LA pressure control.

Keywords:
heart failureinteratrial shunt devicesleft atrial pressure

More Related Videos

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

10.1K
Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

14.3K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
3
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
6
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
4